Small beat in Q4 and news of CEO leaving Adj. EBITDA up 2.
Redeye is pleased to note that Smart Eye announced two new interior sensing design wins worth SEK100...
Både försäljning och rörelseresultat överträffade våra förväntningar för fjärde kvartalet.
Etteplan’s Q4 performance aligned with our expectations.
Marimekko reports its Q4/24 figures on 19th of February.
Q4e: Germany likely stagnant, US solid 12-9x '25e-'26e EV/EBIT, distributor peers at 14-13x De-lever...
Sales +7% and EBIT +34% vs. ABGSCe Organic growth of +13%, above ABGSCe +6% Limited but positive con...
NoHo Partners reported Q4 EBIT of EUR 15.1m (+42%% y/y), 19% above Vara Research consensus and 13% a...
Taaleri’s group continuing earnings grew 6% y/y to EUR 10.
5%/3% adj. EBITA vs ABGSCe/cons in Q4 Estimates likely up low single digit on adj.
Q4 EBIT of SEK 63m, +19% vs. ABGSC and +13% vs. cons.
Pirepemat topline data coming closer IRL757 passes Ph 1 successfully Webcast today at 10:00 CET Eve...
Nettoomsättningen för det tredje kvartalet uppgick till 119,6 MSEK (99,8), vilket motsvarade en orga...
Redeye views the Q4 report as uneventful in many respects, as most of the events were communicated d...
Redeye retains its view of Hanza following a Q4 report showing a relatively solid performance in a s...
EBITA grew 37% y-o-y Sees positive signals in the Swedish project market Trading at 9x '25e EV/EBITA...
Beat on adj. EBIT but lower OCF Adj. EBIT up 8.9-9.
On February 11th, Eevia Health Plc (publ) (“Eevia”) announced multiple new sales orders for products...
Analyst Group inleder idag den 11:e februari 2024 analysbevakning på Hifab Group (”Hifab”, ”Koncerne...
Q4 report due on 21 February Q4e sales: EUR 47m, order intake: EUR 43m Several orders announced duri...